8.10 USD
↘ 0.13 (1.58%)AT CLOSE (11:59 AM EDT)
Emergent Biosolutions, Inc.
EBSNYSE • USD
8.31
↗ 0.10 (1.19%)
POST MARKET (AS OF 06:33 PM EDT)
Post Market
AS OF 06:33 PM EDT
8.31
↗ 0.10 (1.19%)
Market: OPEN
Open?$8.21
High?$8.32
Low?$8.09
Prev. Close?$8.23
Volume?557.8K
Avg. Volume?1.1M
VWAP?$8.21
Rel. Volume?0.50x
Bid / Ask
Bid?$8.07 × 1.0K
Ask?$8.32 × 100
Spread?$0.25
Midpoint?$8.20
Valuation & Ratios
Market Cap?425.0M
Shares Out?51.6M
Float?50.0M
Float %?96.6%
P/E Ratio?8.08
P/B Ratio?0.81
EPS?$1.02
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.98Strong
Quick Ratio?2.39Strong
Cash Ratio?1.55Strong
Debt/Equity?1.09Moderate
ValuationATTRACTIVELY VALUED
Score100/100
P/E?8.1CHEAP▾
P/B?0.81CHEAP▾
P/S?0.57CHEAP▾
P/FCF?2.7CHEAP▾
EV/EBITDA?3.8CHEAP▾
EV/Sales?1.07CHEAP▾
Returns & Efficiency
ROE?10.1%FAIR▾
ROA?4.0%FAIR▾
Cash Flow & Enterprise
FCF?$156.8M
Enterprise Value?$791.7M
Related Companies
Loading...
News
Profile
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Employees
900
Market Cap
425.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2006-11-15
Address
300 PROFESSIONAL DR
GAITHERSBURG, MD 20879
Phone: 240-631-3200
GAITHERSBURG, MD 20879
Phone: 240-631-3200